J.Carl Barrett

J. Carl Barrett is an accomplished scientist and executive in the field of translational medicine and oncology research. He currently serves as the Chief Scientific Officer at Precede Biosciences, a company focused on revolutionizing precision medicine through innovative liquid biopsy technology.14

Career Highlights

Dr. Barrett has an extensive and impressive career spanning academia, government research, and the pharmaceutical industry:

• Current Role: Chief Scientific Officer at Precede Biosciences since 202314
• Previous Positions:
  • Vice President of Translational Medicine at AstraZeneca Oncology (2011-2023)12
  • Global Head of Oncology Biomarkers and Imaging at Novartis (2005-2011)12
  • Founding Director of the NCI Center for Cancer Research (CCR)2
  • Scientific Director at the National Institute of Environmental Health Sciences2

Education and Expertise

• Education: Ph.D. in Biophysical Chemistry from Johns Hopkins University12
• Areas of Expertise: Translational medicine, biomarker strategies, cancer research, genomics, proteomics, and drug development2

Achievements and Contributions

Dr. Barrett has made significant contributions to cancer research and drug development:

• Contributed to the discovery of critical genetic and epigenetic changes in cancer cells, including genes involved in breast cancer (BRCA1), cellular senescence (SIRTs, TERT), and cancer metastasis (KAI1)2
• Played a key role in the development of multiple drugs and diagnostics in the pharmaceutical industry2
• Published over 600 research articles and reviews2
• Received multiple NIH awards and delivered numerous keynote lectures2

Professional Recognition

• Member of the Johns Hopkins University Society of Scholars2
• Elected member of the Ramazini Foundation2
• Honorary member of the Japanese Cancer Association2

At Precede Biosciences, Dr. Barrett is part of a team working on a breakthrough liquid biopsy platform that aims to provide unprecedented insights into disease-defining biology from a simple blood test.34